n-Butyl-2-cyanoacrylate (1ml)

Clinical Pharmacologist's Monograph

⚠️ Prescription Only: This medicine is Schedule H/H1. Do not self-medicate.

1. Clinical Overview

n-Butyl-2-cyanoacrylate is a liquid surgical adhesive belonging to the cyanoacrylate class of tissue glues. It is a sterile, low-viscosity, synthetic monomer that polymerizes rapidly upon contact with moisture (e.g., blood, tissue fluids) to form a strong, flexible film, creating an immediate mechanical seal. In the Indian clinical context, it is primarily used as an adjunct to sutures/staples for topical skin closure and for the embolization of vascular malformations. It is not a systemic drug but a medical device/hemostatic agent.

OnsetDurationBioavailability
Immediate (polymerization occurs within 10-60 seconds upon application to a moist surface).The polymer film typically sloughs off with the natural exfoliation of the epidermis in 5 to 10 days. For internal vascular applications, the embolic effect is permanent.Not applicable (N/A). It is a topical/local acting agent with no systemic absorption intended.

2. Mechanism of Action

n-Butyl-2-cyanoacrylate (n-BCA) is a monomeric liquid. Its mechanism is physical and chemical, not pharmacological. Upon contact with anions present in moisture (e.g., OH- ions in water, blood, tissue fluids), it undergoes rapid anionic polymerization. This exothermic reaction forms long chains of poly(n-butyl-2-cyanoacrylate), creating a solid, flexible film that binds to the underlying tissue. This film acts as a mechanical barrier, approximates wound edges, and provides hemostasis by sealing small vessels.

3. Indications & Uses

  • Topical closure of surgical skin incisions and traumatic lacerations (as an adjunct to or replacement for sutures/staples)
  • Embolization of cerebral arteriovenous malformations (AVMs) and fistulas (when mixed with ethiodized oil for radiopacity and controlled polymerization)
  • Embolization of gastric varices (e.g., via BRTO - Balloon-occluded Retrograde Transvenous Obliteration procedure)

4. Dosage & Administration

Adult Dosage: Topical: Apply the minimal amount (1-2 drops) needed to form a thin film over the approximated wound edges. 1ml vial is typically sufficient for multiple small incisions or a single long incision. Embolization: Dose is highly variable and determined by the interventional radiologist/neurosurgeon based on AVM/variceal size and flow dynamics. It is often diluted with ethiodized oil (e.g., Lipiodol) in ratios from 1:1 to 1:4.

Administration: 1. For topical use: Clean and dry wound area as much as possible. Approximate wound edges with fingers, forceps, or subcutaneous sutures. Hold applicator tip 0.5-1 cm above wound. Apply in a continuous, thin line along the length of the incision. Allow 30-60 seconds to polymerize. Do not apply in a thick layer or between wound edges. 2. For embolization: A specialized catheter delivery system is used under fluoroscopic guidance. The n-BCA is mixed with ethiodized oil for visualization. Injection must be precise and rapid to avoid catheter adhesion. The procedure is performed by a trained specialist in an angiography suite.

5. Side Effects

Common side effects may include:

  • Transient localized warmth or burning sensation during polymerization
  • Erythema (redness) around application site
  • Itching or mild dermatitis under the film
  • Visible, slightly raised polymer film on skin

6. Drug Interactions

DrugEffectSeverity
Anticoagulants (Warfarin, DOACs) / Antiplatelets (Clopidogrel, Aspirin)Increased risk of bleeding at site before adhesive application; may compromise hemostatic efficacy of the glue. No direct interaction with polymer.Moderate
Topical Antibiotics (Neomycin, Bacitracin) or Antiseptics (Povidone-Iodine)Application under the glue film may trap moisture, preventing polymerization or promoting infection. Apply adhesive only to clean, dry skin.Moderate
Topical CorticosteroidsMay impair wound healing and increase risk of dehiscence when used under adhesive.Moderate

7. Patient Counselling

  • DO keep the glued area clean and dry for the first 24-48 hours.
  • DO report any signs of infection (increased redness, swelling, pain, pus, fever).
  • DON'T pick, scratch, or peel the glue film. Let it fall off naturally (5-10 days).
  • DON'T apply ointments, creams, or oils directly on the glue, as they may cause it to soften and detach early.
  • DON'T soak the area in water (e.g., swimming, long baths) for prolonged periods in the first week.
  • DON'T expose the area to direct sunlight excessively, as it may cause hyperpigmentation.

8. Toxicology & Storage

Overdose: Overdose' is not a systemic concept. Local overdose manifests as: 1) Thick, rigid polymer film that cracks and fails prematurely. 2) Excessive exothermic reaction causing thermal tissue injury. 3) In embolization, non-target embolization leading to ischemia/infarction of brain, lungs, or other organs.

Storage: Store in a cool, dry place. Protect from moisture. Store at room temperature (15-25°C). Do not refrigerate or freeze. Keep in the original sealed pouch until use. The vial is for single-use only; discard any unused portion. Do not use if the vial is cracked or the seal is broken. Keep out of reach of children.